BD is one of the largest global medical technology companies in the world and is advancing the world of health🅪 by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 75,0000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.
We are thrilled to share the recent publication “Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel “. These recommendations were provided by a panel consisted of 17 Canadian physicians, including 12 radiologists, 2 pathologists, and 3 surgeons from 6 provinces across Canada.
The publication includes an analysis of 347 individual items, with 286 (82%) achieving consensus. These recommendations aim to help standardize and improve breast biopsy practices across Canada and are endorsed by the Canadian Society of Breast Imaging (CSBI).
We encourage you to read the full publication and consider how these recommendations can be integrated into your practice. Together, we can advance
breast cancer care and support better health outcomes for patients.
Discover BD’s solution of vacuum assisted breast biopsy solutions:
EnCor Enspireâ„¢ Breast Biopsy System
BD EleVationâ„¢ Breast Biopsy System
UltraCorâ„¢ Twirlâ„¢ Breast Tissue Marker